Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: CLOZAPINE Response in Biotype-1 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Clozapine response in Biotype-1 is currently recruiting at UT Southwestern, studying schizophrenia, schizoaffective disorder, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: RECRUITING